Haloperidol
- Product NDC
- 27241-264
- 11-digit product format
- 272410264
- Labeler code
- 27241
- Product ID
- 27241-264_3af25358-362b-4046-98c9-1c12eb623e02
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Haloperidol
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Ajanta Pharma USA Inc.
- Application
- ANDA218210
- Marketing category
- ANDA
- Marketing start
- 2026-09-14
- Substance
- HALOPERIDOL
- Active strength
- .5 mg/1
- Pharmacologic classes
- Typical Antipsychotic [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Source provenance: Browse the complete Orange Book source catalog.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Haloperidol
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| HALOPERIDOL | .5 mg/1 |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 27241-264-01 | 27241026401 | 100 TABLET in 1 BOTTLE (27241-264-01) | 100 tablet | 2026-09-14 | No | No | Current |